Nel ASA

Board/Management Information • Jan 31, 2014

New CEO and new Company address

New CEO and new Company address

Ruben Ekbråten (37) has been appointed as the new Chief Executive

Officer (CEO) of DiaGenic ASA effective from 1st February 2014. The

appointment is temporary for 2 months. Ruben Ekbråten holds the position

as Chief Financial Officer (CFO) in DiaGenic ASA. In addition to his 6

years tenure at DiaGenic he has international experience from several

positions within finance at GE Healthcare. Ruben Ekbråten holds an MBA

from Heriot Watt University, and a BBA from Norwegian School of

Management.

"The Board of DiaGenic are very pleased that Ruben Ekbråten has accepted

to be appointed acting CEO. This is an important phase for the company,

and the constitution of Ruben Ekbråten ensure competence and continuity

in safeguarding the company's affairs" says Chairman Hanne S. Holen.

With reference to the stock exchange notice on 10th January the Company

announced reduction in payment obligations based on inter alia earlier

termination of the facility lease. As a consequence, the Company will

move to new facilities effective from 1st February 2014. The new address

for DiaGenic ASA is:

Sjølyst plass 2, 0278 Oslo, Norway

Contact:

Hanne Skaarberg Holen, Chairman of the Board, +47 982 94 591